SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-045043
Filing Date
2021-02-16
Accepted
2021-02-16 16:43:59
Documents
12
Period of Report
2021-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d96205d8k.htm   iXBRL 8-K 25961
  Complete submission text file 0001193125-21-045043.txt   145124

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA reph-20210209.xsd EX-101.SCH 3079
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20210209_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20210209_pre.xml EX-101.PRE 10959
5 EXTRACTED XBRL INSTANCE DOCUMENT d96205d8k_htm.xml XML 3260
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 21639858
SIC: 2834 Pharmaceutical Preparations